Altfest L J & Company Decreased Procter & Gamble Co (PG) Position By $591,955; Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Shorts Up By 2.51%

May 23, 2018 - By Marguerite Chambers

Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE) Logo

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) had an increase of 2.51% in short interest. AMPE’s SI was 9.09 million shares in May as released by FINRA. Its up 2.51% from 8.86 million shares previously. With 981,000 avg volume, 9 days are for Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE)’s short sellers to cover AMPE’s short positions. The SI to Ampio Pharmaceuticals Inc’s float is 14.07%. The stock increased 5.69% or $0.12 during the last trading session, reaching $2.23. About 566,684 shares traded. Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE) has risen 279.13% since May 23, 2017 and is uptrending. It has outperformed by 267.58% the S&P500.

Altfest L J & Company Inc decreased Procter & Gamble Co (PG) stake by 47% reported in 2017Q4 SEC filing. Altfest L J & Company Inc sold 6,505 shares as Procter & Gamble Co (PG)’s stock declined 15.56%. The Altfest L J & Company Inc holds 7,336 shares with $674,000 value, down from 13,841 last quarter. Procter & Gamble Co now has $186.59B valuation. The stock increased 0.24% or $0.1743 during the last trading session, reaching $74.2043. About 4.11M shares traded. The Procter & Gamble Company (NYSE:PG) has declined 14.03% since May 23, 2017 and is downtrending. It has underperformed by 25.58% the S&P500.

Investors sentiment increased to 2.3 in 2017 Q4. Its up 1.75, from 0.55 in 2017Q3. It improved, as 2 investors sold Ampio Pharmaceuticals, Inc. shares while 8 reduced holdings. 12 funds opened positions while 11 raised stakes. 8.34 million shares or 25.18% more from 6.66 million shares in 2017Q3 were reported. Pennsylvania-based Wealthtrust Axiom Limited Liability has invested 0.01% in Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE). Creative Planning has invested 0% in Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE). Brandes Investment Prtnrs Limited Partnership accumulated 50,000 shares. Moreover, Cypress Management Limited Liability Com (Wy) has 0.5% invested in Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE). Condor Capital stated it has 21,400 shares or 0.02% of all its holdings. Virtu Fin Ltd stated it has 0.02% of its portfolio in Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE). Raymond James Financial Advsrs reported 24,000 shares or 0% of all its holdings. Grp One Trading Ltd Partnership reported 0.01% in Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE). Knoll Cap Mngmt L P invested in 9.31% or 2.60M shares. Blackrock Inc holds 0% or 1.23M shares. Raymond James Assoc accumulated 33,630 shares or 0% of the stock. Utd Financial Advisers Ltd Company owns 18,472 shares or 0% of their US portfolio. 185,406 were reported by Millennium Limited Liability. 18,150 were reported by Jfs Wealth Lc. 20,500 are owned by California Pub Employees Retirement Systems.

Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company has market cap of $192.50 million. The firm is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. It currently has negative earnings. The Company’s product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, which has completed Phase II clinical trials for diabetic macular edema.

Altfest L J & Company Inc increased Spdr S&P Biotech Etf (XBI) stake by 15,501 shares to 24,562 valued at $2.09 million in 2017Q4. It also upped Lam Research Corp. (NASDAQ:LRCX) stake by 2,904 shares and now owns 7,476 shares. Gilead Sciences Inc was raised too.

Among 25 analysts covering Proctor & Gamble (NYSE:PG), 10 have Buy rating, 1 Sell and 14 Hold. Therefore 40% are positive. Proctor & Gamble had 89 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, October 17 by Jefferies. The stock of The Procter & Gamble Company (NYSE:PG) has “Overweight” rating given on Thursday, October 29 by Barclays Capital. The firm has “Hold” rating by RBC Capital Markets given on Tuesday, September 5. The firm has “Buy” rating by Jefferies given on Wednesday, June 15. The firm has “Buy” rating given on Wednesday, October 12 by Argus Research. The firm has “Buy” rating given on Tuesday, August 25 by Vetr. The stock has “Hold” rating by Argus Research on Friday, April 20. The stock has “Hold” rating by Stifel Nicolaus on Wednesday, December 21. Stifel Nicolaus maintained the shares of PG in report on Thursday, July 27 with “Hold” rating. TheStreet downgraded the stock to “Hold” rating in Tuesday, August 4 report.

Analysts await The Procter & Gamble Company (NYSE:PG) to report earnings on July, 26. They expect $0.91 earnings per share, up 7.06% or $0.06 from last year’s $0.85 per share. PG’s profit will be $2.29B for 20.39 P/E if the $0.91 EPS becomes a reality. After $1.00 actual earnings per share reported by The Procter & Gamble Company for the previous quarter, Wall Street now forecasts -9.00% negative EPS growth.

Since February 15, 2018, it had 0 buys, and 6 insider sales for $6.67 million activity. Pritchard Marc S. had sold 8,502 shares worth $668,179. Fish Kathleen B sold $1.93 million worth of stock or 23,500 shares. Another trade for 2,075 shares valued at $149,130 was sold by Bishop Steven D. $739,189 worth of The Procter & Gamble Company (NYSE:PG) was sold by Posada Juan Fernando. $3.07 million worth of stock was sold by Schomburger Jeffrey K on Thursday, February 15.

Investors sentiment increased to 0.89 in Q4 2017. Its up 0.07, from 0.82 in 2017Q3. It increased, as 64 investors sold PG shares while 740 reduced holdings. 118 funds opened positions while 594 raised stakes. 1.47 billion shares or 1.61% less from 1.50 billion shares in 2017Q3 were reported. M holds 43,161 shares or 0.38% of its portfolio. Segall Bryant & Hamill Ltd has invested 0.3% in The Procter & Gamble Company (NYSE:PG). Pinnacle Ptnrs Inc has 85,754 shares. Johnson Grp Inc Inc owns 50,389 shares or 0.57% of their US portfolio. Walter & Keenan Fincl Consulting Mi Adv accumulated 2.26% or 58,556 shares. Hartford Investment Management holds 0.96% or 565,732 shares in its portfolio. Jump Trading Limited Liability Corp invested 0.09% of its portfolio in The Procter & Gamble Company (NYSE:PG). Mirae Asset Global Invests Company holds 0.08% or 65,774 shares. Garrison owns 35,787 shares or 1.72% of their US portfolio. Franklin Inc stated it has 0.3% in The Procter & Gamble Company (NYSE:PG). Ftb has 114,591 shares for 1% of their portfolio. Strategic Global Advsrs Ltd holds 7,407 shares or 0.22% of its portfolio. Clean Yield Gru holds 44,386 shares. 695,005 are owned by Avalon Advsrs Ltd Liability Corporation. Guardian Investment invested in 2.81% or 29,034 shares.

The Procter & Gamble Company (NYSE:PG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: